NCT07463235 2026-03-13
SPARAGMOS
University of Sao Paulo General Hospital
Phase 3 Recruiting
Clinical Trials
6 trialsNCT07045935 2025-09-23
ProBOLIC
University Hospital, Basel, Switzerland
Phase 4 Recruiting
NCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
NCT01620138 2016-08-22
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
Universidade Federal do Rio de Janeiro
Phase 2/3 Completed
NCT01143584 2010-06-14
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
PIMERIndia
Phase NA Unknown
NCT00460616 2008-04-16
ValveCab
Federico II University
Completed